These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 15670486)
1. [A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha]. Mao QG; Liu DL; Zhang MX; Feng XR; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):24-6. PubMed ID: 15670486 [TBL] [Abstract][Full Text] [Related]
2. [Generation of neutralizing anti-interferon antibodies and factors influencing their production in chronic hepatitis B patients receiving recombinant interferon-alpha treatment]. Mao QG; Luo KX; Zhang MX; Liu D; Hou JL Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1319-22. PubMed ID: 14678902 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha]. Mao QG; Luo KX; Liu DL; Zhang MX; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):205-7. PubMed ID: 15099466 [TBL] [Abstract][Full Text] [Related]
4. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up]. Liu DL; Luo KX; Feng XR; Fu QX; Hou JL Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996 [TBL] [Abstract][Full Text] [Related]
5. [Viral breakthrough and neutralizing anti-interferon antibody production in chronic hepatitis B patients treated with recombinant interferon-alpha]. Liu DL; Luo KX; Feng XR; Zhang MX; Hou JL Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):422-4. PubMed ID: 17594805 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of interferon-alpha therapy for HBeAg-negative chronic hepatitis B and its influencing factors]. Mao QG; Luo KX; Fu QF; Feng XR; Guo YB; Zhu YF; Peng J; Hou JJ Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):582-4. PubMed ID: 15504285 [TBL] [Abstract][Full Text] [Related]
7. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2. Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327 [TBL] [Abstract][Full Text] [Related]
8. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770 [TBL] [Abstract][Full Text] [Related]
9. [The influence of interferon alpha neutralizing antibodies on the therapeutic effectiveness in patients with chronic viral hepatitis]. Tong F; Tang Y; Bai J Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):345-7. PubMed ID: 12759973 [TBL] [Abstract][Full Text] [Related]
10. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients. Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901 [TBL] [Abstract][Full Text] [Related]
11. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha. van der Eijk AA; Niesters HG; Hansen BE; Heijtink RA; Janssen HL; Schalm SW; de Man RA J Viral Hepat; 2006 Feb; 13(2):96-103. PubMed ID: 16436127 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B core antigen expression pattern reflects the response to anti-viral treatment. Uzun Y; Bozkaya H; Erden E; Cinar K; Idilman R; Yurdaydin C; Uzunalimoglu O J Gastroenterol Hepatol; 2006 Jun; 21(6):977-81. PubMed ID: 16724981 [TBL] [Abstract][Full Text] [Related]
13. [Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine]. Xu QH; Zhang XH; Xie DY; Li JG; Chong YT; Yang L; Lu WL; Gao ZL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):334-6. PubMed ID: 18322594 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of antiviral treatment on intrahepatic HBV DNA and histology in HBeAg -positive chronic hepatitis B patients]. Lu HY; Zhuang LW; Yu YY; Si CW; Zheng JJ; Chen XY; Han ZH; Chen Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Feb; 22(1):54-6. PubMed ID: 18414702 [TBL] [Abstract][Full Text] [Related]
15. [Role of neutralizing anti-interferon antibodies during interferon therapy in patients with chronic hepatitis B]. Wang YP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):304-6. PubMed ID: 20108781 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial. Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B. Hellström U; Lindh M; Krogsgaard K; Sylvan S J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371 [TBL] [Abstract][Full Text] [Related]
18. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B. Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775 [TBL] [Abstract][Full Text] [Related]
19. [Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients]. Zhu M; Xu B; Yao GB Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):534-6. PubMed ID: 16042894 [TBL] [Abstract][Full Text] [Related]
20. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment. Sarin SK; Kumar M; Hissar S; Sharma BC Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]